Dorota Danielak,
Ph.D., dr hab.
A pharmacist by training, is a graduate of the Poznan University of Medical Sciences and obtained her PhD in clinical pharmacokinetics in 2014. During her academic career from 2009 to 2024, she explored the genetic determinants of pharmacokinetic variability and population PK modeling.
In 2024, she joined Physiolution as a full-time employee and now assumes the role of an R&D Manager, leading Physiolution’s PK-related projects. In her work, she integrates biopredictive dissolution testing with mechanistic pharmacokinetic (PK) modeling. Her recent research is centered on the development of physiologically driven in vitro-in vivo extrapolations (IVIVE), utilizing the advanced PhysioCell apparatus to accurately simulate the complexities of gastric motility and inter-subject variability.
Her career is marked by a strong commitment to international collaboration, including EU-funded research secondments at Zentiva in Prague and Physiolution in Greifswald. As an experienced academic educator, former associate professor, and guest lecturer within the CEEPUS network and Jagiellonian University, she frequently shares her expertise at premier global forums, including AAPS PharmSci360, the Nordic PoP International Symposium, APV, and M-CERSI.
